Lori Hu

Lori Hu is currently serving as a Board Director at Neuspera Medical, Inc. and Indapta Therapeutics, Inc. She also holds the position of Director at BlackThorn Therapeutics, Inc. and Palleon Pharmaceuticals, Inc. Additionally, she is a Director at SonoThera, Inc. and serves as a Board Observer at Moximed, Inc. In her former roles, Ms. Hu worked as an Associate Director-Business Development at Bristol Myers Squibb Co. and as a Director at Kona Medical, Inc. She also served as an Independent Director at Elevation Oncology, Inc. from 2019 to 2024 and as a Board Observer at Ivantis, Inc. from 2015 to 2022.
Ms. Hu completed her graduate studies at the University of Pennsylvania and holds an MBA from The Wharton School of the University of Pennsylvania.
She obtained her undergraduate degree from Duke University.